---
document_datetime: 2025-12-02 06:26:22
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/hepsera.html
document_name: hepsera.html
version: success
processing_time: 0.1098643
conversion_datetime: 2025-12-28 14:53:25.664138
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Hepsera

[RSS](/en/individual-human-medicine.xml/65677)

##### Withdrawn

This medicine's authorisation has been withdrawn

adefovir dipivoxil Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 31 December 2022, the European Commission withdrew the marketing authorisation for Hepsera (adefovir dipivoxil) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Gilead Sciences Ireland UC, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Hepsera was granted marketing authorisation in the EU on 6 March 2003 for the treatment of adults with chronic hepatitis B. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2008.

The European Public Assessment Report (EPAR) for Hepsera is updated to indicate that the marketing authorisation is no longer valid.

Hepsera : EPAR - Summary for the public

English (EN) (1.22 MB - PDF)

**First published:** 09/07/2009

**Last updated:** 01/03/2023

[View](/en/documents/overview/hepsera-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-316)

български (BG) (761.8 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/bg/documents/overview/hepsera-epar-summary-public_bg.pdf)

español (ES) (665.37 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/es/documents/overview/hepsera-epar-summary-public_es.pdf)

čeština (CS) (761.86 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/cs/documents/overview/hepsera-epar-summary-public_cs.pdf)

dansk (DA) (685.24 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/da/documents/overview/hepsera-epar-summary-public_da.pdf)

Deutsch (DE) (689.96 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/de/documents/overview/hepsera-epar-summary-public_de.pdf)

eesti keel (ET) (80.11 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/et/documents/overview/hepsera-epar-summary-public_et.pdf)

ελληνικά (EL) (804.03 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/el/documents/overview/hepsera-epar-summary-public_el.pdf)

français (FR) (688.54 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/fr/documents/overview/hepsera-epar-summary-public_fr.pdf)

italiano (IT) (684.29 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/it/documents/overview/hepsera-epar-summary-public_it.pdf)

latviešu valoda (LV) (718.64 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/lv/documents/overview/hepsera-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (710.92 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/lt/documents/overview/hepsera-epar-summary-public_lt.pdf)

magyar (HU) (758.46 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/hu/documents/overview/hepsera-epar-summary-public_hu.pdf)

Malti (MT) (765.58 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/mt/documents/overview/hepsera-epar-summary-public_mt.pdf)

Nederlands (NL) (687.76 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/nl/documents/overview/hepsera-epar-summary-public_nl.pdf)

polski (PL) (761.1 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/pl/documents/overview/hepsera-epar-summary-public_pl.pdf)

português (PT) (686.36 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/pt/documents/overview/hepsera-epar-summary-public_pt.pdf)

română (RO) (713.07 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/ro/documents/overview/hepsera-epar-summary-public_ro.pdf)

slovenčina (SK) (702.73 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/sk/documents/overview/hepsera-epar-summary-public_sk.pdf)

slovenščina (SL) (752.35 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/sl/documents/overview/hepsera-epar-summary-public_sl.pdf)

Suomi (FI) (684.14 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/fi/documents/overview/hepsera-epar-summary-public_fi.pdf)

svenska (SV) (688.22 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/sv/documents/overview/hepsera-epar-summary-public_sv.pdf)

Hepsera : EPAR - Risk-management-plan summary

English (EN) (683.38 KB - PDF)

**First published:** 08/08/2019

**Last updated:** 01/03/2023

[View](/en/documents/rmp-summary/hepsera-epar-risk-management-plan-summary_en.pdf)

## Product information

Hepsera : EPAR - Product Information

English (EN) (1.09 MB - PDF)

**First published:** 09/07/2009

**Last updated:** 01/03/2023

[View](/en/documents/product-information/hepsera-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-700)

български (BG) (1.9 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/bg/documents/product-information/hepsera-epar-product-information_bg.pdf)

español (ES) (1.15 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/es/documents/product-information/hepsera-epar-product-information_es.pdf)

čeština (CS) (1.67 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/cs/documents/product-information/hepsera-epar-product-information_cs.pdf)

dansk (DA) (1.1 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/da/documents/product-information/hepsera-epar-product-information_da.pdf)

Deutsch (DE) (1.15 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/de/documents/product-information/hepsera-epar-product-information_de.pdf)

eesti keel (ET) (388.92 KB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/et/documents/product-information/hepsera-epar-product-information_et.pdf)

ελληνικά (EL) (2 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/el/documents/product-information/hepsera-epar-product-information_el.pdf)

français (FR) (1.2 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/fr/documents/product-information/hepsera-epar-product-information_fr.pdf)

hrvatski (HR) (1.22 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/hr/documents/product-information/hepsera-epar-product-information_hr.pdf)

íslenska (IS) (1.09 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/is/documents/product-information/hepsera-epar-product-information_is.pdf)

italiano (IT) (1.15 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/it/documents/product-information/hepsera-epar-product-information_it.pdf)

latviešu valoda (LV) (1.68 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/lv/documents/product-information/hepsera-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.21 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/lt/documents/product-information/hepsera-epar-product-information_lt.pdf)

magyar (HU) (1.65 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/hu/documents/product-information/hepsera-epar-product-information_hu.pdf)

Malti (MT) (1.74 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/mt/documents/product-information/hepsera-epar-product-information_mt.pdf)

Nederlands (NL) (1.09 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/nl/documents/product-information/hepsera-epar-product-information_nl.pdf)

norsk (NO) (1.16 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/no/documents/product-information/hepsera-epar-product-information_no.pdf)

polski (PL) (1.7 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/pl/documents/product-information/hepsera-epar-product-information_pl.pdf)

português (PT) (1.09 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/pt/documents/product-information/hepsera-epar-product-information_pt.pdf)

română (RO) (1.21 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/ro/documents/product-information/hepsera-epar-product-information_ro.pdf)

slovenčina (SK) (1.65 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/sk/documents/product-information/hepsera-epar-product-information_sk.pdf)

slovenščina (SL) (1.65 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/sl/documents/product-information/hepsera-epar-product-information_sl.pdf)

Suomi (FI) (1.14 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/fi/documents/product-information/hepsera-epar-product-information_fi.pdf)

svenska (SV) (1.08 MB - PDF)

**First published:**

09/07/2009

**Last updated:**

01/03/2023

[View](/sv/documents/product-information/hepsera-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0086 20/04/2021

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Hepsera : EPAR - All Authorised presentations

English (EN) (594.58 KB - PDF)

**First published:** 24/10/2006

**Last updated:** 01/03/2023

[View](/en/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-341)

български (BG) (632.5 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/bg/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_bg.pdf)

español (ES) (589.1 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/es/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_es.pdf)

čeština (CS) (611.81 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/cs/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (588.73 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/da/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (588.54 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/de/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (17.06 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/et/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (631.42 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/el/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_el.pdf)

français (FR) (588.95 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/fr/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (632.08 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/hr/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (588.68 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/is/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_is.pdf)

italiano (IT) (588.85 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/it/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (621.95 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/lv/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (606.67 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/lt/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (619.31 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/hu/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (616.94 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/mt/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (588.66 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/nl/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (588.61 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/no/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_no.pdf)

polski (PL) (612.31 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/pl/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_pl.pdf)

português (PT) (588.84 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/pt/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_pt.pdf)

română (RO) (604.92 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/ro/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (611.47 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/sk/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (610.57 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/sl/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (589.74 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/fi/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (588.62 KB - PDF)

**First published:**

24/10/2006

**Last updated:**

01/03/2023

[View](/sv/documents/all-authorised-presentations/hepsera-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Hepsera Active substance adefovir dipivoxil International non-proprietary name (INN) or common name adefovir dipivoxil Therapeutic area (MeSH) Hepatitis B, Chronic Anatomical therapeutic chemical (ATC) code J05AF08

### Pharmacotherapeutic group

Nucleoside and nucleotide reverse transcriptase inhibitors

### Therapeutic indication

Hepsera is indicated for the treatment of chronic hepatitis B in adults with:

- compensated liver disease with evidence of active viral replication, persistently elevated serum-alanine-aminotransferase (ALT) levels and histological evidence of active liver inflammation and fibrosis. Initiation of Hepsera treatment should only be considered when the use of an alternative antiviral agent with a higher genetic barrier to resistance is not available or appropriate (see section 5.1);
- decompensated liver disease in combination with a second agent without cross-resistance to Hepsera.

## Authorisation details

EMA product number EMEA/H/C/000485 Marketing authorisation holder

Gilead Sciences Ireland UC

IDA Business &amp; Technology Park

Opinion adopted 21/11/2002 Marketing authorisation issued 06/03/2003 Withdrawal of marketing authorisation 31/12/2022 Revision 27

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Hepsera : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (1000.04 KB - PDF)

**First published:** 09/07/2009

**Last updated:** 01/03/2023

[View](/en/documents/procedural-steps-after/hepsera-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Hepsera-H-C-485-PSUSA-00000060-201809 : EPAR - Scientific Conclusion

Adopted

Reference Number: EMA/443748/2019

English (EN) (648.82 KB - PDF)

**First published:** 08/08/2019

**Last updated:** 01/03/2023

[View](/en/documents/scientific-conclusion/hepsera-h-c-485-psusa-00000060-201809-epar-scientific-conclusion_en.pdf)

Hepsera-H-C-485-FUM-0062 : EPAR - Assessment Report

Adopted

Reference Number: EMA/275269/2013

English (EN) (744.97 KB - PDF)

**First published:** 27/05/2013

**Last updated:** 01/03/2023

[View](/en/documents/variation-report/hepsera-h-c-485-fum-0062-epar-assessment-report_en.pdf)

Hepsera-H-C-485-P46-0066 : EPAR - Assessment Report

Adopted

Reference Number: EMA/CHMP/52392/2013

English (EN) (1.26 MB - PDF)

**First published:** 11/02/2013

**Last updated:** 01/03/2023

[View](/en/documents/variation-report/hepsera-h-c-485-p46-0066-epar-assessment-report_en.pdf)

Hepsera-H-C-485-II-0030 : EPAR - Assessment Report - Variation

English (EN) (746.64 KB - PDF)

**First published:** 10/04/2008

**Last updated:** 01/03/2023

[View](/en/documents/variation-report/hepsera-h-c-485-ii-0030-epar-assessment-report-variation_en.pdf)

## Initial marketing authorisation documents

Hepsera : EPAR - Scientific Discussion

English (EN) (1.14 MB - PDF)

**First published:** 24/10/2006

**Last updated:** 01/03/2023

[View](/en/documents/scientific-discussion/hepsera-epar-scientific-discussion_en.pdf)

Hepsera : EPAR - Procedural steps taken before authorisation

English (EN) (664.94 KB - PDF)

**First published:** 24/10/2006

**Last updated:** 01/03/2023

[View](/en/documents/procedural-steps/hepsera-epar-procedural-steps-taken-authorisation_en.pdf)

**This page was last updated on** 06/03/2023

## Share this page

[Back to top](#main-content)